To access any content or REGISTER in less than 3 minutes.
Register
Menu
Are you medical worker?
No, visit
Your account was deleted
Please login to MyServier to continue reading this content

Don't have an account? REGISTER

You already have an account associated with this email address. Please log in to continue.

Don't have an account? REGISTER

Forgot Password?
Please enter the email address here. We will then immediately send you a link with which you can create a new password.
Your email
Link sent successfully
Check the email sent to you for further instructions. Check your junk folder if you can't find it.

Video

  • Diabetes and Metabolism
  • Ischemic Heart Disease
  • Type 2 Diabetes

Pharmacological Management in Uncontrolled T2D in 2025: Role of FDCs for Optimizing Adherence

You are registered for this event You have rejected invitation for this event
27.02.2026
4

In this video, Dr. Suhail Ahmad Durani explains early fixed-dose combination therapy for type 2 diabetes, highlighting improved adherence, reduced pill burden, individualized choices, and complication prevention.

Dr. Suhail Ahmad Durani – Clinical Diabetologist – Fortis Memorial and Research Institute, Gurugram

Watch the full video to learn more!

Content exclusive for connected users. Please sign in or register to access more.

Already have an account?

New here?

Create account

Related content: